Maltofer

Ferric Hydroxide Polymaltose Complex, the active ingredient in Maltofer, is an iron supplement presented as an oral formulation for oral use. It is used to treat iron deficiency anemia and other forms of iron deficiency in children and adults.

GNH USA supplies Maltofer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maltofer is an oral iron supplement that addresses conditions caused by insufficient iron. - Iron deficiency anemia: restores hemoglobin concentration and replenishes depleted iron stores. - Iron deficiency without anemia: supports normal iron metabolism and prevents progression to anemia. - Chronic blood loss (e.g., gastrointestinal bleeding): compensates for ongoing iron loss and aids recovery of iron balance.

Adverse reactions may occur with oral iron therapy.

Common Side Effects: - Nausea: mild to moderate discomfort in the stomach. - Abdominal discomfort: cramping or pain in the abdomen. - Constipation: reduced bowel movements or hard stools. - Diarrhea: loose, watery stools. - Darkened stools: harmless change in stool color. - Metallic taste: transient metallic sensation in the mouth.

Serious or Rare Side Effects: - Hypersensitivity reactions: rash, itching, or swelling. - Severe abdominal pain: persistent or worsening pain. - Anaphylaxis (rare): sudden difficulty breathing, throat swelling. - Iron overload: signs of excess iron accumulation. - Significant hypotension: marked drop in blood pressure.

Before prescribing Maltofer, clinicians should evaluate patient-specific factors and monitor therapy. - Assess iron status before initiating: confirm diagnosis of iron deficiency through laboratory tests. - Monitor hemoglobin and ferritin levels: adjust therapy based on response. - Use with caution in patients with inflammatory bowel disease: absorption may be impaired. - Avoid in known hypersensitivity to ferric hydroxide polymaltose: discontinue if reaction occurs. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Iron supplements can affect the absorption or efficacy of several medicines.

Major Interactions (Avoid): - Tetracycline antibiotics: chelation reduces antibiotic absorption. - Fluoroquinolone antibiotics: chelation decreases antibiotic bioavailability. - Levothyroxine: iron interferes with thyroid hormone absorption. - Bisphosphonates: concurrent intake diminishes both agents' effectiveness. - Calcium‑containing antacids: form insoluble complexes, reducing iron uptake.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may lower gastric acidity, modestly reducing iron absorption. - Food rich in phytates (e.g., whole grains): can modestly decrease iron uptake. - Vitamin C supplements: may enhance iron absorption, requiring dose adjustment.